
Thinking translational: Things to consider in CAR T cell research workflows
S Rösch, PhD

Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
The lack of a robust, scalable solution for autologous cell therapy fill-finish has ensured that this vital final step in the bioprocess remains fraught with challenges. Typically, industry has been forced to resort to a suboptimal, manual syringe and manifold approach.
This webinar examine the very latest technology and its capability to deliver the commercially ready, small volume fill-finish instrument required by industry. In addition, a diverse panel offering expert drug developer, CMO/CRO and tool provider perspectives explore future partnering models and methods for accelerating the novel product development process and further advancing the cell and gene therapy industry.